Review





Similar Products

alpha/beta specific cardiac myosin heavy chain primary antibodies ma1-26180  (Thermo Fisher)
90
Thermo Fisher alpha/beta specific cardiac myosin heavy chain primary antibodies ma1-26180
Alpha/Beta Specific Cardiac Myosin Heavy Chain Primary Antibodies Ma1 26180, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/beta+myosin+heavy+chain/alpha+beta+specific+cardiac+myosin+heavy+chain+primary+antibodies+ma1+26180/pmc12263785-127-8-19
Average 90 stars, based on 1 article reviews
alpha/beta specific cardiac myosin heavy chain primary antibodies ma1-26180 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
β myosin heavy chain myh7 r403q gene variant ☆ chad m warren  (Bristol Myers)
86
Bristol Myers β myosin heavy chain myh7 r403q gene variant ☆ chad m warren
β Myosin Heavy Chain Myh7 R403q Gene Variant ☆ Chad M Warren, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/beta+myosin+heavy+chain/chad+chain+gene+heavy+m+myh7+myosin+r403q+variant%E2%98%86+warren+%CE%B2/pm41282547-11-11-62
Average 86 stars, based on 1 article reviews
β myosin heavy chain myh7 r403q gene variant ☆ chad m warren - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
β myosin heavy chain  (Janssen)
86
Janssen β myosin heavy chain
β Myosin Heavy Chain, supplied by Janssen, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/beta+myosin+heavy+chain/chain+heavy+isoform+myosin/pm41206632-556-39-21
Average 86 stars, based on 1 article reviews
β myosin heavy chain - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
beta myosin heavy chain β mhc  (Proteintech)
96
Proteintech beta myosin heavy chain β mhc
Beta Myosin Heavy Chain β Mhc, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/beta+myosin+heavy+chain/HRP-conjugated+Heavy+chain+of+Rabbit+IgG+Antibody/pm41203038-80-46-51
Average 96 stars, based on 1 article reviews
beta myosin heavy chain β mhc - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
anti β-myosin heavy chain (β-mhc)  (Proteintech)
96
Proteintech anti β-myosin heavy chain (β-mhc)
Anti β Myosin Heavy Chain (β Mhc), supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/beta+myosin+heavy+chain/HRP-conjugated+Heavy+chain+of+Rabbit+IgG+Antibody/pm40795597-47-0-14
Average 96 stars, based on 1 article reviews
anti β-myosin heavy chain (β-mhc) - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
mouse anti β mhc antibody  (R&D Systems)
96
R&D Systems mouse anti β mhc antibody
Pharmacological inhibition of IL12β attenuated TAC-induced cardiac dysfunction, LV hypertrophy, increases in lung weight, and RV hypertrophy in mice. (A) Schematic diagram of the experimental design. (B) Representative M-mode echocardiographic images of the indicated groups. (C–H) Quantified data of echocardiographic measurements of LV ejection fraction (LVEF), LV fractional shortening (LVFS), LV end-systolic diameter (LVESD), LV end-diastolic diameter (LVEDD), LV end-systolic volume (LVESV), and LV end-diastolic volume (LVEDV), respectively. (I) The ratio of LV weight, left atrial (LA) weight, lung weight, RV weight, right atrial (RA), and total heart weight to tibial length (TL) of the indicated groups. (J, K) Representative wheat germ agglutinin (WGA) staining images and quantified data of LV cardiomyocyte cross-sectional area of the indicated groups. (L, M) Representative images and quantification of <t>β-MHC</t> expression in LV tissues of the indicated groups. *p<0.05; # p<0.05 IgG-treated TAC mice compared with the control; † p<0.05 anti-IL12β-treated TAC mice compared with IgG-treated TAC mice; $ p<0.05 anti-IL12β-treated TAC mice compared with the control; n = 5–7 mice per group.
Mouse Anti β Mhc Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/beta+myosin+heavy+chain/Myosin+Heavy+Chain+Antibody/pmc12395052-58-16-19
Average 96 stars, based on 1 article reviews
mouse anti β mhc antibody - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
beta myosin heavy chain β myhc  (Proteintech)
96
Proteintech beta myosin heavy chain β myhc
Pharmacological inhibition of IL12β attenuated TAC-induced cardiac dysfunction, LV hypertrophy, increases in lung weight, and RV hypertrophy in mice. (A) Schematic diagram of the experimental design. (B) Representative M-mode echocardiographic images of the indicated groups. (C–H) Quantified data of echocardiographic measurements of LV ejection fraction (LVEF), LV fractional shortening (LVFS), LV end-systolic diameter (LVESD), LV end-diastolic diameter (LVEDD), LV end-systolic volume (LVESV), and LV end-diastolic volume (LVEDV), respectively. (I) The ratio of LV weight, left atrial (LA) weight, lung weight, RV weight, right atrial (RA), and total heart weight to tibial length (TL) of the indicated groups. (J, K) Representative wheat germ agglutinin (WGA) staining images and quantified data of LV cardiomyocyte cross-sectional area of the indicated groups. (L, M) Representative images and quantification of <t>β-MHC</t> expression in LV tissues of the indicated groups. *p<0.05; # p<0.05 IgG-treated TAC mice compared with the control; † p<0.05 anti-IL12β-treated TAC mice compared with IgG-treated TAC mice; $ p<0.05 anti-IL12β-treated TAC mice compared with the control; n = 5–7 mice per group.
Beta Myosin Heavy Chain β Myhc, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/beta+myosin+heavy+chain/MYH7-specific+Antibody/pm40500343-43-18-50
Average 96 stars, based on 1 article reviews
beta myosin heavy chain β myhc - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
factor product reference common antibodies myosin heavy chain β myh7  (Santa Cruz Biotechnology)
94
Santa Cruz Biotechnology factor product reference common antibodies myosin heavy chain β myh7
Pharmacological inhibition of IL12β attenuated TAC-induced cardiac dysfunction, LV hypertrophy, increases in lung weight, and RV hypertrophy in mice. (A) Schematic diagram of the experimental design. (B) Representative M-mode echocardiographic images of the indicated groups. (C–H) Quantified data of echocardiographic measurements of LV ejection fraction (LVEF), LV fractional shortening (LVFS), LV end-systolic diameter (LVESD), LV end-diastolic diameter (LVEDD), LV end-systolic volume (LVESV), and LV end-diastolic volume (LVEDV), respectively. (I) The ratio of LV weight, left atrial (LA) weight, lung weight, RV weight, right atrial (RA), and total heart weight to tibial length (TL) of the indicated groups. (J, K) Representative wheat germ agglutinin (WGA) staining images and quantified data of LV cardiomyocyte cross-sectional area of the indicated groups. (L, M) Representative images and quantification of <t>β-MHC</t> expression in LV tissues of the indicated groups. *p<0.05; # p<0.05 IgG-treated TAC mice compared with the control; † p<0.05 anti-IL12β-treated TAC mice compared with IgG-treated TAC mice; $ p<0.05 anti-IL12β-treated TAC mice compared with the control; n = 5–7 mice per group.
Factor Product Reference Common Antibodies Myosin Heavy Chain β Myh7, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/beta+myosin+heavy+chain/MYH7+Antibody/pm39615619-265-4-15
Average 94 stars, based on 1 article reviews
factor product reference common antibodies myosin heavy chain β myh7 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
beta myosin heavy chain  (Proteintech)
96
Proteintech beta myosin heavy chain
Pharmacological inhibition of IL12β attenuated TAC-induced cardiac dysfunction, LV hypertrophy, increases in lung weight, and RV hypertrophy in mice. (A) Schematic diagram of the experimental design. (B) Representative M-mode echocardiographic images of the indicated groups. (C–H) Quantified data of echocardiographic measurements of LV ejection fraction (LVEF), LV fractional shortening (LVFS), LV end-systolic diameter (LVESD), LV end-diastolic diameter (LVEDD), LV end-systolic volume (LVESV), and LV end-diastolic volume (LVEDV), respectively. (I) The ratio of LV weight, left atrial (LA) weight, lung weight, RV weight, right atrial (RA), and total heart weight to tibial length (TL) of the indicated groups. (J, K) Representative wheat germ agglutinin (WGA) staining images and quantified data of LV cardiomyocyte cross-sectional area of the indicated groups. (L, M) Representative images and quantification of <t>β-MHC</t> expression in LV tissues of the indicated groups. *p<0.05; # p<0.05 IgG-treated TAC mice compared with the control; † p<0.05 anti-IL12β-treated TAC mice compared with IgG-treated TAC mice; $ p<0.05 anti-IL12β-treated TAC mice compared with the control; n = 5–7 mice per group.
Beta Myosin Heavy Chain, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/beta+myosin+heavy+chain/HRP-conjugated+Heavy+chain+of+Rabbit+IgG+Antibody/pmc11072575-201-20-48
Average 96 stars, based on 1 article reviews
beta myosin heavy chain - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

Image Search Results


Pharmacological inhibition of IL12β attenuated TAC-induced cardiac dysfunction, LV hypertrophy, increases in lung weight, and RV hypertrophy in mice. (A) Schematic diagram of the experimental design. (B) Representative M-mode echocardiographic images of the indicated groups. (C–H) Quantified data of echocardiographic measurements of LV ejection fraction (LVEF), LV fractional shortening (LVFS), LV end-systolic diameter (LVESD), LV end-diastolic diameter (LVEDD), LV end-systolic volume (LVESV), and LV end-diastolic volume (LVEDV), respectively. (I) The ratio of LV weight, left atrial (LA) weight, lung weight, RV weight, right atrial (RA), and total heart weight to tibial length (TL) of the indicated groups. (J, K) Representative wheat germ agglutinin (WGA) staining images and quantified data of LV cardiomyocyte cross-sectional area of the indicated groups. (L, M) Representative images and quantification of β-MHC expression in LV tissues of the indicated groups. *p<0.05; # p<0.05 IgG-treated TAC mice compared with the control; † p<0.05 anti-IL12β-treated TAC mice compared with IgG-treated TAC mice; $ p<0.05 anti-IL12β-treated TAC mice compared with the control; n = 5–7 mice per group.

Journal: Frontiers in Immunology

Article Title: Pharmacological inhibition of IL12β is effective in treating pressure overload-induced cardiac inflammation and heart failure

doi: 10.3389/fimmu.2025.1624940

Figure Lengend Snippet: Pharmacological inhibition of IL12β attenuated TAC-induced cardiac dysfunction, LV hypertrophy, increases in lung weight, and RV hypertrophy in mice. (A) Schematic diagram of the experimental design. (B) Representative M-mode echocardiographic images of the indicated groups. (C–H) Quantified data of echocardiographic measurements of LV ejection fraction (LVEF), LV fractional shortening (LVFS), LV end-systolic diameter (LVESD), LV end-diastolic diameter (LVEDD), LV end-systolic volume (LVESV), and LV end-diastolic volume (LVEDV), respectively. (I) The ratio of LV weight, left atrial (LA) weight, lung weight, RV weight, right atrial (RA), and total heart weight to tibial length (TL) of the indicated groups. (J, K) Representative wheat germ agglutinin (WGA) staining images and quantified data of LV cardiomyocyte cross-sectional area of the indicated groups. (L, M) Representative images and quantification of β-MHC expression in LV tissues of the indicated groups. *p<0.05; # p<0.05 IgG-treated TAC mice compared with the control; † p<0.05 anti-IL12β-treated TAC mice compared with IgG-treated TAC mice; $ p<0.05 anti-IL12β-treated TAC mice compared with the control; n = 5–7 mice per group.

Article Snippet: Relative expression of β-myosin heavy chain (β-MHC) in LV and RV tissues was determined by using mouse anti-β-MHC antibody (R&D Systems, MAB4470, 5μg/mL) and Alexa Flour-555 conjugated goat anti-mouse secondary antibody (Invitrogen, A21424, 1:1000 dilution).

Techniques: Inhibition, Staining, Expressing, Control